Renaissance Technologies
UTHR icon

Renaissance Technologies’s United Therapeutics UTHR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$609M Buy
2,119,092
+12,100
+0.6% +$3.48M 0.81% 12
2025
Q1
$650M Buy
2,106,992
+17,600
+0.8% +$5.43M 0.98% 6
2024
Q4
$737M Sell
2,089,392
-66,000
-3% -$23.3M 1.09% 2
2024
Q3
$772M Sell
2,155,392
-19,300
-0.9% -$6.92M 1.16% 3
2024
Q2
$693M Buy
2,174,692
+22,978
+1% +$7.32M 1.18% 5
2024
Q1
$494M Sell
2,151,714
-18,500
-0.9% -$4.25M 0.78% 10
2023
Q4
$477M Sell
2,170,214
-80,294
-4% -$17.7M 0.74% 11
2023
Q3
$508M Buy
2,250,508
+63,294
+3% +$14.3M 0.87% 10
2023
Q2
$483M Sell
2,187,214
-40,200
-2% -$8.87M 0.7% 13
2023
Q1
$499M Sell
2,227,414
-117,078
-5% -$26.2M 0.66% 12
2022
Q4
$652M Sell
2,344,492
-205,722
-8% -$57.2M 0.89% 6
2022
Q3
$534M Sell
2,550,214
-243,377
-9% -$51M 0.76% 11
2022
Q2
$658M Buy
2,793,591
+28,378
+1% +$6.69M 0.78% 11
2022
Q1
$496M Sell
2,765,213
-151,978
-5% -$27.3M 0.58% 23
2021
Q4
$630M Sell
2,917,191
-111,400
-4% -$24.1M 0.78% 9
2021
Q3
$559M Sell
3,028,591
-81,600
-3% -$15.1M 0.72% 16
2021
Q2
$558M Sell
3,110,191
-97,400
-3% -$17.5M 0.7% 17
2021
Q1
$537M Sell
3,207,591
-399,700
-11% -$66.9M 0.67% 16
2020
Q4
$548M Sell
3,607,291
-101,727
-3% -$15.4M 0.59% 22
2020
Q3
$375M Sell
3,709,018
-17,800
-0.5% -$1.8M 0.37% 50
2020
Q2
$451M Buy
3,726,818
+136,595
+4% +$16.5M 0.39% 47
2020
Q1
$340M Buy
3,590,223
+45,790
+1% +$4.34M 0.33% 55
2019
Q4
$312M Buy
3,544,433
+332,155
+10% +$29.3M 0.24% 79
2019
Q3
$256M Buy
3,212,278
+171,300
+6% +$13.7M 0.22% 96
2019
Q2
$237M Buy
3,040,978
+799,200
+36% +$62.4M 0.21% 100
2019
Q1
$263M Buy
2,241,778
+45,000
+2% +$5.28M 0.24% 82
2018
Q4
$239M Buy
2,196,778
+252,700
+13% +$27.5M 0.26% 70
2018
Q3
$249M Buy
1,944,078
+387,878
+25% +$49.6M 0.26% 69
2018
Q2
$176M Buy
1,556,200
+22,322
+1% +$2.53M 0.19% 98
2018
Q1
$172M Buy
1,533,878
+71,500
+5% +$8.03M 0.19% 97
2017
Q4
$216M Buy
1,462,378
+189,378
+15% +$28M 0.24% 67
2017
Q3
$149M Buy
1,273,000
+435,400
+52% +$51M 0.18% 111
2017
Q2
$109M Buy
837,600
+331,400
+65% +$43M 0.14% 155
2017
Q1
$68.5M Buy
506,200
+85,000
+20% +$11.5M 0.1% 248
2016
Q4
$60.4M Buy
421,200
+31,100
+8% +$4.46M 0.1% 256
2016
Q3
$46.1M Sell
390,100
-14,200
-4% -$1.68M 0.08% 302
2016
Q2
$42.8M Sell
404,300
-70,278
-15% -$7.44M 0.08% 312
2016
Q1
$52.9M Sell
474,578
-77,500
-14% -$8.64M 0.1% 224
2015
Q4
$86.5M Sell
552,078
-314,700
-36% -$49.3M 0.19% 85
2015
Q3
$114M Buy
866,778
+55,200
+7% +$7.24M 0.27% 49
2015
Q2
$141M Buy
811,578
+365,078
+82% +$63.5M 0.32% 37
2015
Q1
$77M Buy
446,500
+261,262
+141% +$45.1M 0.16% 113
2014
Q4
$24M Buy
185,238
+182,860
+7,690% +$23.7M 0.06% 415
2014
Q3
$306K Sell
2,378
-250,100
-99% -$32.2M ﹤0.01% 2470
2014
Q2
$22.3M Sell
252,478
-35,462
-12% -$3.14M 0.05% 422
2014
Q1
$27.1M Buy
287,940
+63,662
+28% +$5.99M 0.06% 369
2013
Q4
$25.4M Sell
224,278
-216,500
-49% -$24.5M 0.06% 387
2013
Q3
$34.8M Sell
440,778
-149,600
-25% -$11.8M 0.08% 275
2013
Q2
$38.9M Buy
+590,378
New +$38.9M 0.1% 235